Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Current Leases (2023 - 2025)

Upstream Bio has reported Current Leases over the past 3 years, most recently at $720000.0 for Q4 2025.

  • Quarterly results put Current Leases at $720000.0 for Q4 2025, up 2.27% from a year ago — trailing twelve months through Dec 2025 was $720000.0 (up 2.27% YoY), and the annual figure for FY2025 was $720000.0, up 2.27%.
  • Current Leases for Q4 2025 was $720000.0 at Upstream Bio, up from $716000.0 in the prior quarter.
  • Over the last five years, Current Leases for UPB hit a ceiling of $720000.0 in Q4 2025 and a floor of $45000.0 in Q4 2023.
  • Median Current Leases over the past 3 years was $708000.0 (2025), compared with a mean of $611857.1.
  • Biggest five-year swings in Current Leases: soared 1464.44% in 2024 and later rose 2.27% in 2025.
  • Upstream Bio's Current Leases stood at $45000.0 in 2023, then soared by 1464.44% to $704000.0 in 2024, then increased by 2.27% to $720000.0 in 2025.
  • The last three reported values for Current Leases were $720000.0 (Q4 2025), $716000.0 (Q3 2025), and $712000.0 (Q2 2025) per Business Quant data.